Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Generated: May 28, 2017

DrugPatentWatch Database Preview

Linezolid - Generic Drug Details

« Back to Dashboard

What are the generic sources for linezolid and what is the scope of linezolid patent protection?

is the generic ingredient in three branded drugs marketed by Sandoz Inc, Gate Pharms, Aurobindo Pharma Ltd, Alkem Labs Ltd, Teva Pharms, Novel Labs Inc, Pharmacia And Upjohn, Alembic Pharms Ltd, Amneal Pharms, Hetero Labs Ltd V, Hospira Inc, Mylan Pharms Inc, Nang Kuang Pharm Co, Teva Pharms Usa, Fresenius Kabi Usa, West-ward Pharms Int, Glenmark Pharms, Sagent Pharms, and Zydus Pharms Usa Inc, and is included in twenty-two NDAs. There are three patents protecting this compound and four Paragraph IV challenges. Additional information is available in the individual branded drug profile pages.

Linezolid has seventy-four patent family members in thirty-six countries.

There are twenty-two drug master file entries for linezolid. Twenty-eight suppliers are listed for this compound.

Summary for Generic Name: linezolid

Drug Master File Entries: see list22
Suppliers / Packagers: see list28
Bulk Api Vendors: see list70
Clinical Trials: see list24
Patent Applications: see list5,603
Therapeutic Class:Antibacterials
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:linezolid at DailyMed

Pharmacology for Ingredient: linezolid

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Pharmacia And Upjohn
SOLUTION;IV (INFUSION)021131-001Apr 18, 2000APRXYesNo6,559,305*PED► SubscribeY► Subscribe
Alembic Pharms Ltd
TABLET;ORAL205233-001Dec 21, 2015ABRXNoNo► Subscribe► Subscribe
Teva Pharms
SOLUTION;IV (INFUSION)200222-001Jun 27, 2012APRXNoNo► Subscribe► Subscribe
Nang Kuang Pharm Co
SOLUTION;IV (INFUSION)207354-002Dec 20, 2016APRXNoNo► Subscribe► Subscribe
Pharmacia And Upjohn
FOR SUSPENSION;ORAL021132-001Apr 18, 2000ABRXYesYes6,559,305*PED► SubscribeY► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Uncover prior art in abandoned patent applications and expired patents
  • Obtain formulation and manufacturing information
  • Drug patents and clinical trials in dozens of countries

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus